National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW 2052, Australia.
Drug Alcohol Depend. 2011 Jun 1;115(3):190-5. doi: 10.1016/j.drugalcdep.2010.10.021. Epub 2010 Dec 3.
The study aimed to determine mortality rates, standardised mortality ratios (SMRs), and correlates of mortality amongst the Australian Treatment Outcome Study (ATOS) cohort of 615 heroin users over the period 2001-2009. The cohort was followed for a total of 4820.1 person years. A total of 31 deaths (5% of the cohort) occurred across follow-up. The mean age at death was 34.5 years, and 58% were male. The most common cause of death was overdose (68%). The crude mortality rate was 6.43 per 1000 person years, with no gender difference, and the SMR was 4.56 (males=2.95, females=18.57). The only significant bivariate (hazard ratio=3.69) and multivariate (adjusted hazard ratio=3.03) correlate of mortality was a history of opioid overdose prior to baseline. Mortality rates were lower than those seen outside Australasia. Screening for overdose by those treating heroin users would be appropriate, and may contribute to reductions in overall mortality.
本研究旨在确定澳大利亚治疗结果研究(ATOS)队列中 615 名海洛因使用者在 2001-2009 年期间的死亡率、标准化死亡率比(SMR)以及死亡率相关因素。该队列共随访了 4820.1 人年。随访期间共发生 31 例死亡(占队列的 5%)。死亡时的平均年龄为 34.5 岁,58%为男性。最常见的死亡原因为过量(68%)。粗死亡率为 6.43/1000 人年,无性别差异,SMR 为 4.56(男性=2.95,女性=18.57)。死亡率的唯一显著单变量(危险比=3.69)和多变量(调整后的危险比=3.03)相关因素是基线前有阿片类药物过量的病史。死亡率低于澳大拉西亚以外地区的死亡率。对海洛因使用者进行过量筛查可能是合适的,并且可能有助于降低总体死亡率。